Please assess the completion status of the following clinical trial:

Trial Title: Pilot Evaluation of the Empower Neuromodulation System in AUD Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Is male or female ≥ 21 year of age at Visit 1~* Has a current diagnosis of alcohol use disorder per DSM-5 by clinician assessment~* Endorses Criterion 4 in DSM-5~* Has a desire to maintain abstinence or, if not abstinent, a desire to reduce or quit alcohol use~* Has a breath alcohol concentration of 0.00% at enrollment~* Is able to provide informed consent~* Is able to understand spoken and written English~* Is capable and willing to follow all study-related procedures~Exclusion Criteria:~* Has been diagnosed with unstable psychosis, epilepsy, peripheral neuropathy, or nerve damage~* Requires acute medical detoxification from alcohol based on a score of 12 or more on the Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA-AD)~* Has implanted electrical and/or neurostimulator device (e.g. pacemaker, defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, sacral stimulator, bone growth stimulator, or cochlear implant)~* Has an electrically conductive metal object (e.g. jewelry) that cannot be removed from the palm and will directly contact the gel electrodes of the Empower Neuromodulation System~* Will not, for the duration of the participation in the study, have a living situation that provides regular access to an electrical outlet.~* Is pregnant, breastfeeding, or unwilling to practice birth control during participation in the study~* Has used an investigational drug/device therapy within the past 4 weeks~* Is deemed unsuitable for enrollment in the study by the PI

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Baseline (Type: NO_INTERVENTION): For the first week of the study, participants will not administer treatment with the Empower device. Participants will complete surveys to establish baseline values for each participant.
- Active treatment (Type: EXPERIMENTAL): Participants will self-administer treatment with the Empower device two times daily for two weeks. Participants will complete surveys over the two-week period to evaluate the effects of the Empower treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).